Cargando…

Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation

IMPORTANCE: The development of an optimal stroke prevention strategy, including the use of oral anticoagulant (OAC) therapy, is particularly important for patients with atrial fibrillation (AF) who are living with dementia, a condition that increases the risk of adverse outcomes. However, data on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Kueiyu Joshua, Singer, Daniel E., Bykov, Katsiaryna, Bessette, Lily G., Mastrorilli, Julianna M., Cervone, Alexander, Kim, Dae Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051113/ https://www.ncbi.nlm.nih.gov/pubmed/36976562 http://dx.doi.org/10.1001/jamanetworkopen.2023.4086

Ejemplares similares

Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
por: Ko, Darae, et al.
Publicado: (2022)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
por: Deitelzweig, Steven, et al.
Publicado: (2019)

Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
por: Iyer, Geetha S., et al.
Publicado: (2023)

Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization
por: Zhang, Yichi, et al.
Publicado: (2023)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

A Novel Chronic Kidney Disease Phenotyping Algorithm Using Combined Electronic Health Record and Claims Data
por: Mansour, Omar, et al.
Publicado: (2023)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation
por: Manning, Evan, et al.
Publicado: (2023)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation
por: Rymer, Jennifer A., et al.
Publicado: (2023)

Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation
por: Derington, Catherine G., et al.
Publicado: (2023)

Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation
por: Black‐Maier, Eric, et al.
Publicado: (2017)

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
por: Lane, Deirdre A., et al.
Publicado: (2018)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries
por: Lim, Toon Wei, et al.
Publicado: (2023)

Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China
por: Gu, Hong-Qiu, et al.
Publicado: (2021)

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants
por: Lip, Gregory Y. H., et al.
Publicado: (2022)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Age at Diagnosis of Atrial Fibrillation and Incident Dementia
por: Zhang, Wenya, et al.
Publicado: (2023)

Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation
por: Fenger-Grøn, Morten, et al.
Publicado: (2021)

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
por: Cadogan, Sharon Louise, et al.
Publicado: (2021)

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2018)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
por: Friberg, Leif, et al.
Publicado: (2019)

Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis
por: Mentias, Amgad, et al.
Publicado: (2018)

Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial
por: Pokorney, Sean D., et al.
Publicado: (2022)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new‐onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study
por: Wang, Jing‐Rong, et al.
Publicado: (2021)

Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2016)

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
por: Silva, Rose Mary Ferreira Lisboa Da, et al.
Publicado: (2019)

Is there a connection among atrial fibrillation, anticoagulant treatment, and dementia?
por: Ferri, Claudio, et al.
Publicado: (2020)

Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy
por: Søgaard, Mette, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ohhq9vfcqn5qnf7lm9dao7fjp7